Patents Represented by Attorney, Agent or Law Firm Paula A. Borden
-
Patent number: 6440102Abstract: An apparatus for delivering fluid materials into and out of the inner ear via the round window membrane. A fluid transfer conduit is provided which includes one or more passageways therethrough which may have a semipermeable membrane associated therewith to control fluid flow. Attached to the conduit is an inflatable bladder sized for insertion within the round window niche. When inflated, the bladder engages the internal side wall of the niche, thereby securing the bladder and part of the conduit within the niche. The conduit can then transfer fluids to and from the niche and the fluid-permeable round window membrane therein. Bladder inflation may be achieved through one of the passageways within the conduit which can deliver an inflation fluid into the bladder. Also, the conduit may include an elongate conductive diagnostic member for transferring electrical potentials to and from the inner ear.Type: GrantFiled: July 23, 1998Date of Patent: August 27, 2002Assignee: Durect CorporationInventors: Irving K. Arenberg, Michael H. Arenberg
-
Patent number: 6432635Abstract: An isolated nucleic acid molecule, wherein the molecule contains: (1) a first sequence consisting of human cystatin B genomic DNA as set forth in FIG. 3 (SEQ ID NO:1); (2) a second sequence, wherein said second sequence is a subsequence of said first sequence, is at least nucleotides in length, and is not present in human cystatin B cDNA; (3) a third sequence in which at least one nucleotide of said first or second sequences is replaced by a different nucleotide; or (4) a fourth sequence complementary to any of said first, second or third sequences; with the proviso that (I) if said molecule is an RNA molecule, U replaces T in said sequence of said molecule, and (ii) said third sequence is at least 95% identical to said first or second sequence.Type: GrantFiled: March 18, 1997Date of Patent: August 13, 2002Assignees: Helsinki University Licensing Ltd. Oy, The Board of Trustees of the Leland Stanford Jr. UniveristyInventors: Richard M. Myers, David R. Cox, Len A. Pennacchio, Anna-Elina Lehesjoki, Albert De La Chapelle
-
Patent number: 6426336Abstract: The invention is directed to a method for treating both the early and late phases of allergic asthma by introducing naked polynucleotides which operatively encode for the asthma-initiating antigen into the host. The antigen-encoding polynucleotides are administered to host tissues which contain a high concentration of antigen presenting cells (e.g., skin and mucosa) relative to other host tissues. Expression of the asthma-initiating antigen encoding polynucleotides of the invention inside of antigen presenting cells (without substantial secretion therefrom) induces antigen tolerance while suppressing IgE antibody formation in the early phase of the disease, and also suppresses cytokine-mediated eosinophil accumulation in the late phase of the disease. Devices and compositions for use in the methods of the invention are also described.Type: GrantFiled: October 12, 2000Date of Patent: July 30, 2002Assignee: The Regents of the University of CaliforniaInventors: Dennis A. Carson, Eval Raz
-
Patent number: 6417205Abstract: The present invention features methods for induction of angiogenesis by administration of nicotine or other nicotine receptor agonist. Induction of angiogenesis by the methods of the invention can be used in therapeutic angiogenesis in, for example, treatment of ischemic syndromes such as coronary or peripheral arterial disease.Type: GrantFiled: July 28, 2000Date of Patent: July 9, 2002Assignee: The Board of Trustees of the Leland Stanford Jr. UniversityInventors: John Cooke, James Jang, Phillip Tsao, Christopher Heeschen
-
Patent number: 6409662Abstract: A patient interface system for collecting and transferring data from a patient to a remote monitoring system, as well as methods for its use, are provided. The subject system comprises: (a) a data collection means comprising an edema sensing means and an interrogation means; (b) a processing means for processing the collected data; and (c) a communication means for transferring said collected data from said interface means to a remote monitoring system and receiving instructional data from a remote monitoring system. The subject system finds use in the remote monitoring of a variety of conditions, particularly in the remote monitoring of cardiac associated diseases.Type: GrantFiled: September 20, 1999Date of Patent: June 25, 2002Assignee: Alere Medical, Inc.Inventors: Lester John Lloyd, Melissa Ann Prince
-
Patent number: 6406890Abstract: The present invention concerns a process for the amplification of nucleic acids, wherein the tailing of the nucleic acid to be amplified is effected by extending the nucleic acid with ribonucleotides at its 3′ end with the aid of terminal transferase. Further, a kit for the amplification of a nucleic acid, which includes at least one ribonucleotide and terminal transferase, is provided.Type: GrantFiled: March 10, 1999Date of Patent: June 18, 2002Inventor: Manfred W. Mueller
-
Patent number: 6395515Abstract: Switch regions derived from an immunoglobulin (Ig) gene are used to direct recombination between a targeting construct containing a promoter, a switch region (S1), and 2) a target locus minimally containing a promoter, a switch region (S2), and a target sequence.Type: GrantFiled: August 6, 1999Date of Patent: May 28, 2002Assignees: Abgenix, Inc., Japan Tobacco, Inc.Inventors: Aya Jakobovits, Michael Lajos Gallo, Xiao-Ping Yang
-
Patent number: 6395882Abstract: Podocalyxin like proteins (e.g. PCLP and PCLP-2) having selectin ligand activity are provided. Also provided are nucleic acid compositions encoding novel PCLP-2 proteins. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies for disease conditions associated with podocalyxin like protein activity. In particular, methods of treating diseases associated with podocalyxin like protein selectin binding activity and/or chemokine presenting activity are provided, where such diseases include inflammation and the like.Type: GrantFiled: February 3, 1999Date of Patent: May 28, 2002Assignee: The Regents of the University of CaliforniaInventors: Steven D. Rosen, Christopher M. Sassetti
-
Patent number: 6383792Abstract: The invention features polynucleotides encoding novel GTP-binding polypeptides, hereinafter referred to as RAQ polypeptides; expression vectors comprising a RAQ polynucleotide of the invention; isolated cells comprising a RAQ-encoding vector; a transgenic non-human animal comprising an alteration in a RAQ gene; and the use of RAQ polynucleotides in detecting in an individual the presence of a genetic polymorphism of a RAQ gene. The invention further features novel RAQ polypeptides; monoclonal antibodies specific for RAQ polypeptides; and a method for making RAQ polypeptides.Type: GrantFiled: December 3, 1999Date of Patent: May 7, 2002Assignee: AxyS Pharmaceuticals, Inc.Inventors: Maxine J. Allen, Marc Rutter, Alan J. Buckler
-
Patent number: 6380374Abstract: A novel human sodium phosphate cotransporter expressed on the apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications. Also provided are methods of inhibiting Npt2B activity in a host and methods of treating disease conditions associated with Npt2B activity.Type: GrantFiled: February 8, 2000Date of Patent: April 30, 2002Assignee: Roche BioscienceInventors: Paul David Cannon, Suryanarayana Sankuratri
-
Patent number: 6380371Abstract: Nucleic acid compositions encoding novel endoglycan proteins, as well as the novel endoglycan proteins, are provided. Also provided are methods of producing the subject nucleic acid and protein compositions. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including diagnostic and therapeutic agent screening applications, as well as in treatment therapies for disease conditions associated with endoglycan activity. In particular, methods of treating diseases associated with endoglycan selectin binding activity and/or chemokine presenting activity are provided, where such diseases include inflammation and the like.Type: GrantFiled: September 13, 1999Date of Patent: April 30, 2002Assignee: The Regents of the University of CaliforniaInventors: Christopher M. Sassetti, Steven D. Rosen
-
Patent number: 6376240Abstract: A novel zinc finger transcription factore (RFLAT-1) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including diagnostic and therapeutic agent screening applications, as well as in treatment therapies. Also provided are methods of treating disease conditions associated with RANTES function, e.g. inflammation, and the like.Type: GrantFiled: January 27, 2000Date of Patent: April 23, 2002Assignee: Board of Trustees of the Leland Stanford Junior UnversityInventors: An M. Song, Ya-Fen Chen, Alan M. Krensky
-
Patent number: 6365365Abstract: A novel human glycosylsulfotransferase expressed in high endothelial cells (GST-3) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications. Also provided are methods of inhibiting selectin mediated binding events and methods of treating disease conditions associated therewith, particularly by administering an inhibitor of at least one of GST-3 or KSGal6ST, or homologues thereof.Type: GrantFiled: November 12, 1998Date of Patent: April 2, 2002Assignee: The Regents of the University of CaliforniaInventors: Annette Bistrup, Steven D. Rosen, Kirsten Tangemann, Stefan Hemmerich
-
Patent number: 6354516Abstract: A nozzle comprising a thin, flexible substantially planar polymeric film having a plurality of pores with structures allowing for generation of an aerosol at reduced extrusion pressure is disclosed. The pores can comprise at least two sections, or steps, in which the thickness of the membrane is reduced in stepwise fashion, or the pores can be tapered. Nozzles formed comprising pores having such structures permit aerosol generation at lower extrusion pressures, thereby allowing for decreased weight of aerosolization devices, increased efficiency, increased portability and increased battery life. The pore structures also allow for the use of thicker, more easily processed polymeric films in manufacturing while having a thinner, more efficient aerosolization area. The use of decreased extrusion pressures also results in increased uniformity in aerosol generation and improved reliability of other components.Type: GrantFiled: November 2, 1999Date of Patent: March 12, 2002Assignee: Aradigm CorporationInventors: Rajesh S. Patel, Sudarsan Srinivasan
-
Patent number: 6351984Abstract: An inspection system and method for inspecting a container are disclosed. The method comprises directing gas under pressure at the container, then detecting any gas which passes through the container material. Also provided is an inspection system which is integrated into a system for manufacturing the containers, and methods for integrated manufacture and inspection of containers.Type: GrantFiled: February 23, 2000Date of Patent: March 5, 2002Assignee: Aradigm CorporationInventor: Sudarsan Srinivasan
-
Patent number: 6335180Abstract: The present invention features vanilloid receptor polypeptides and vanilloid receptor-related polypeptides, specifically the capsaicin receptor subtypes VR1 and VR2 (VRRP-1), as well as the encoding polynucleotide sequences. In related aspects the invention features expression vectors and host cells comprising such polynucleotides. In other related aspects, the invention features transgenic animals having altered capsaicin receptor expression, due to, for example, the presence of an exogenous wild-type or modified capsaicin receptor-encoding polynucleotide sequence. The present invention also relates to antibodies that bind specifically to a capsaicin receptor polypeptide, and methods for producing these polypeptides. Further, the invention provides methods for using capsaicin receptor, including methods for screening candidate agents for activity as agonists or antagonists of capsaicin receptor activity, as well as assays to determine the amount of a capsaicin receptor-activating agent in a sample.Type: GrantFiled: January 22, 1999Date of Patent: January 1, 2002Assignee: The Regents of the University of CaliforniaInventors: David J. Julius, Michael J. Caterina, Anthony J. Brake
-
Patent number: 6329368Abstract: Methods for modulating the endocrine system of a mammal are provided. In the subject methods, a positive allosteric modulator of AMPA receptors of the hypothalamus are administered to the host. The subject methods find use in applications where it is desired to increase the circulatory level of a hormone in a mammalian host, such as diseased states characterized by abnormally depressed circulatory levels of the hormone.Type: GrantFiled: May 9, 1997Date of Patent: December 11, 2001Assignee: The Regents of the University of CaliforniaInventors: Peter Van Der Klish, Gary Lynch
-
Patent number: 6312913Abstract: The present invention provides methods for determining nucleic acid sequences based on known sequences adjacent to the unknown sequences, and reagents for using such methods.Type: GrantFiled: July 21, 2000Date of Patent: November 6, 2001Assignee: Incyte Genomics, Inc.Inventors: Jonathan T. Wang, Glenn K. Fu, Walter H. Lee, Laura L. Stuve
-
Patent number: 6303327Abstract: The invention under consideration concerns a gene-trapping construct containing a first reporter gene which after activation can activate a second reporter gene, and the use of this gene-trapping construct for identification and isolation of genes, especially genes transiently expressed. The invention under consideration furthermore concerns a cell, preferably a mammalian cell, containing the abovementioned gene-trapping construct. The invention under consideration in addition concerns the use of this mammalian cell for identification and/or isolation of genes, particularly transient genes. Furthermore the invention concerns a vector containing the abovementioned gene-trapping construct, as well as a kit for identification and/or isolation of genes, especially transient genes, that contains at least the abovementioned gene-trapping construct or the abovementioned vector.Type: GrantFiled: September 8, 1999Date of Patent: October 16, 2001Inventors: Harald Von Melchner, Dieter Hölzer
-
Patent number: 6295986Abstract: A method for producing a nozzle useful in generating a fine aerosol for delivery of a therapeutic or diagnostic agent is provided. The method comprises treating a thin, preferably flexible material having partially formed nozzles with a plasma which alters the size and shape of the nozzles. The pores in the nozzles so formed preferably have an unflexed exit aperture diameter in the range of about 0.5 to about 25 microns, depending on the size of the aerosol particles desired for a given application. The pores in the nozzles can have a variety of shapes and can be distributed in a variety of patterns. An elevated area can be formed around the exit aperture of the nozzle in order to prevent intrusion of liquid back into the nozzle. A method of producing an aerosolization device incorporating such a nozzle is also provided.Type: GrantFiled: January 12, 2000Date of Patent: October 2, 2001Assignee: Aradigm CorporationInventors: Rajesh S. Patel, Sudarsan Srinivasan